Healthcare / Diagnostics & Research

Danaher Corporation (DHR)

$176.11
-2.09%
$129.3B
Market Cap
35.5
P/E Ratio
0.84
Beta
0.88%
Dividend Yield
Piotroski 4/9Altman Z 3.9 SafeBeneish M -2.56 CleanROIC−WACC -5.4%

Quantitative Summary

Deterministic

At 35.5x earnings — a 46% discount to the sector average of 65.2x — DHR is in the lower valuation range. Financial health is average: Piotroski 4/9, Altman Z 3.9. DCF fair value of $45 implies 77% downside based on model assumptions.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

Danaher Corporation presents a fundamental profile characterized by significant capital inefficiency despite respectable profitability margins. The core economic engine is underperforming, as the return on invested capital of 4.6% falls substantially below the weighted average cost of capital of 10.0%, generating a negative spread of -5.3%. This indicates that new investments are currently destroying value rather than creating it. While the DuPont decomposition reveals strong pricing power with net margins at 14.7%, this is offset by low asset turnover of 0.29x and moderate leverage, resulting in an ROE of only 6.9%. Quality metrics further reflect these structural challenges; a Piotroski F-Score of 4/9 signals weak financial momentum, while the Profitability Factor alpha of -10.2% confirms deteriorating returns relative to peers. Although the Altman Z-Score of 4.0 suggests low bankruptcy risk and the Beneish M-Score of -2.56 indicates limited earnings manipulation concerns, the underlying capital allocation efficiency remains a primary constraint on long-term value creation.

Valuation metrics suggest the market is pricing in aggressive growth assumptions that may not align with current operational realities. The stock trades at 38.0x forward P/E, significantly above the sector average of 30.8x, implying high expectations for future expansion. However, a discounted cash flow analysis places fair value at $46, reflecting an implied ten-year free cash flow growth rate of only 14.4%. This creates a substantial valuation gap where current prices imply nearly double-digit upside relative to the DCF model's intrinsic worth, resulting in a calculated downside risk of -75.6% from current levels if those high-growth assumptions prove unfounded. The negative Fama-French alpha of -19.01% reinforces that the stock has underperformed on both size and value dimensions over time, suggesting the premium valuation may be difficult to sustain given the lack of growth factor outperformance.

Risk factors are amplified by recent insider activity and specific style factor weaknesses. Over the past 90 days, insiders have executed net selling totaling $274,575, a signal that often precedes periods of consolidation or value re-rating when management anticipates headwinds. The stock exhibits clear exposure to growth tilt risks with an HML score of -0.164 and profitability drag from the RMW factor at -0.102. These data points collectively highlight a scenario where high valuation multiples are supported by optimistic long-term growth projections, yet current capital returns and insider sentiment suggest potential vulnerability if execution slows or market conditions shift toward value-oriented styles.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive
Market Price
$176.11
Fair Value
$45
Implied Upside
-74.4%
$45IMPLIED FAIR VALUEOVERVALUEDOVERUNDER
Growth Rate (Y1–5)-8%
-10%20%50%
Discount Rate (WACC)10.1%
5%12.5%20%

5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.

Reverse DCFMarket-Implied
15.1%annual FCF growth priced in at $176.11

The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 3% YoY revenue.

Sensitivity Matrix

TG ↓ / WACC →8.1%10.1%12.1%
2%$57$40$29
3%$68$45$32
4%$84$53$36

Center = base case. Green = >10% upside, Red = >10% downside vs $176.11.

Pre-computed DCF: WACC=10.1%, terminal growth 3%. Fair value $45 (-76.9%). Not investment advice.

Valuation Context

35.5x
DHR P/E
65.2x
Sector Avg
47.5x
5Y Avg P/E
-46%
vs Sector

Currently trading 20% below its 5-year average P/E of 47.5x.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Technical Setup

AI Generated

The current technical configuration for Danaher Corporation presents a complex picture regarding institutional positioning, characterized by the intersection of price action and moving average dynamics. With shares trading at $171.12 within the healthcare sector, the proximity to key simple moving averages suggests that larger market participants are currently in a state of consolidation or indecision rather than displaying aggressive directional conviction. The lack of significant volume expansion alongside these price levels often indicates that institutional accumulation or distribution is occurring quietly, potentially waiting for clearer catalysts before committing substantial capital flows. Institutional behavior appears cautious as the stock navigates this equilibrium zone without breaking decisively above resistance or falling below support thresholds defined by recent trend lines. The absence of a sharp divergence between volume spikes and price movements implies that major holders may be rebalancing their portfolios rather than initiating new, large-scale positions in either direction. This pattern frequently precedes a period where larger players assess fundamental shifts before making definitive moves, resulting in the observed sideways volatility. Consequently, the market structure currently reflects a waiting game among sophisticated investors who are monitoring for confirmation of sustained momentum before altering their exposure levels significantly.

RSI (14)
SMA 50
SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
3.9
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.56
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

59.1%
Gross Margin
14.7%
Net Margin
4.6%
ROIC
10.1%
WACC
ROIC − WACC Spread: -5.4%— Negative spread.
+2.9%
Revenue Growth (YoY)
-7.3%
Earnings Growth (YoY)
5.3B
Free Cash Flow
17%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

14.7%
Net Profit Margin
NI ÷ Revenue
×
0.29x
Asset Turnover
Revenue ÷ Assets
×
1.59x
Equity Multiplier
Assets ÷ Equity
=
6.9%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

0.59x
Debt / Equity
1.87x
Current Ratio
17.0x
Interest Coverage
2.0x
Net Debt / EBITDA
3.55%
FCF Yield
6.9B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
$-274,575
Net Selling
0
Buy Transactions
1
Sale Transactions
2026-02-27RALES MITCHELL PSold 1/8 qtrsOther71,648 shares
2026-02-27BLAIR RAINER MSold 2/8 qtrsGrant17,566 shares
2026-02-27GUTIERREZ-RAMOS JOSE-CARLOSGrant6,647 shares
2026-02-27MCGREW MATTHEWSold 3/8 qtrsGrant5,935 shares
2026-02-27GRAY ROBERT BRADLEYGrant2,849 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $1.64
Act: $1.88
+14.4%
Q3
✓ Beat
Est: $1.64
Act: $1.80
+9.5%
Q2
✓ Beat
Est: $1.72
Act: $1.89
+9.8%
Q1
✓ Beat
Est: $2.19
Act: $2.23
+2.0%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Dividend History

$0.4000
Latest Dividend
$1.28
2025 Total
+18.5%
YoY Growth
8 yrs
Consecutive Increases
Annual Dividends per Share
$24.78
2016
$0.50
2017
$0.57
2018
$0.60
2019
$0.64
2020
$0.74
2021
$0.89
2022
$0.99
2023
$1.08
2024
$1.28
2025
$0.40
2026
DateAmountChange
2026-03-27$0.4000+25.0%
2025-12-26$0.32000.0%
2025-09-26$0.32000.0%
2025-06-27$0.32000.0%
2025-03-28$0.3200+18.5%
2024-12-27$0.27000.0%
2024-09-27$0.27000.0%
2024-06-28$0.27000.0%
2024-03-27$0.2700+12.5%
2023-12-28$0.2400-11.1%
2023-10-11$0.2700+12.8%
2023-06-29$0.23940.0%
Stock Splits
2023-10-02: 1.128:12016-07-05: 1.319:12010-06-14: 2:12004-05-21: 2:11998-06-01: 2:11995-01-23: 2:11987-09-09: 2:1

Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.

Risk Profile

31.6%
Annual Volatility
0.07
Sharpe (1Y)
-25.0%
Max Drawdown (5Y)

Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fama-French 5-Factor Exposure

Academic factor model decomposition — what's really driving this stock's returns.

0.94
Market β
Mkt-RF
+0.190
Size (SMB)
Small-cap tilt
-0.164
Value (HML)
Growth tilt
-0.102
Profit (RMW)
Weak
+1.418
Invest (CMA)
Conservative
Alpha (annual): -19.01%
R²: 45.0%of variance explained by 5 factors

Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.

Fundamentals

20.1
Forward P/E
1.16
PEG Ratio
2.44
Price/Book
5M
Avg Volume
$242.80
52W High
$160.93
52W Low
19%
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$13.8B
Tracked Passive Exposure
8
ETFs Holding DHR
0.23%
Avg Weight in ETFs
$6.1T
Total ETF AUM

When investors buy or sell ETFs like MOAT or XLV, the fund manager is mechanically forced to buy or sell DHR shares regardless of Danaher Corporation's individual fundamentals. We estimate $13.8B of passive capital is structurally linked to DHR through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in Danaher Corporation to visualize passive redemption contagion across ETFs and collateral stocks.

DHR Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
DHREpicenterVTIETFVOOETFIVVETFLLYLow RiskLLYLow RiskJNJLow RiskJNJLow RiskABBVMed Risk
DHR Price Drop (%)0

If Danaher Corporation (DHR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Eli Lilly & Co. (LLY) as the most exposed collateral stock, sharing 2 ETFs with DHR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 27 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

DHR Ownership Dynamics

Passive funds hold 1 in every 9 DHR shares, reducing daily market volatility.

Ticker
DHR
Total Shares
708M
ETF Lock-Up
11.1%
Display Mode
Total Float Impact
11.1%Locked Float

Danaher Corporation (DHR) exerts measurable gravity on the passive index market, currently representing 2.7% of the MOAT (MOAT) and 2.0% of the State Street Health Care Select Sector SPDR ETF (XLV). Across 27 tracked ETFs, approximately 78M shares (11.1% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.

Float lock-up computed from 27 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

DHR Institutional Volume Profile

252-day volume distribution by price level. The Point of Control (POC) marks the price where the most institutional volume transacted — an implicit support/resistance floor.

TICKER
DHR
PRICE
$176.11
FLOOR (POC)
$195.73
STRENGTH
Medium
$163$167$171$175$176.11$179$183$1886%$1929%$196POC 11%$2008%$2049%$2087%$2126%$216$220$2247%$228$233$237$241
Focus Zone
Point of Control (POC) Support (below price) Resistance (above price) Current Price

The highest-volume price zone for Danaher Corporation over the past year sits near $195.73 (11% of 252-day volume). The current price of $176.11 sits 10.0% below the POC — suggesting potential mean-reversion upside if institutional demand reasserts at this level.

Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.

DHR Capital Efficiency

How efficiently does Danaher Corporation convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$5.3B
EBITDA
$6.9B
FCF Conversion
76%
Reinvestment Rate
24%
76% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
4.6%
ROIC − WACC Spread
-5.4%

Danaher Corporation converts 76% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-5.4%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1116,015$171.16$2.7M
2026-04-27637$177.25$112,908.25
2026-04-24110$178.57$19,642.7
2026-04-20391$194.75$76,147.25
2026-04-156$198.61$1,191.66
2026-04-102$192.99$385.98
2026-04-0697$191.12$18,538.64
2026-03-2563$190.10$11,976.3
2026-03-23679$189.35$128,568.65
2026-03-05155$204.73$31,733.15
2026-03-025,000$210.64$1.1M
2026-01-20135$235.99$31,858.65
2026-01-065,520$235.36$1.3M
2026-01-056,662$230.40$1.5M
2025-12-291$230.32$230.32
2025-12-241,598$230.83$368,866.34
2025-12-231$228.01$228.01
2025-12-191,333$224.35$299,058.55
2025-12-18295,579$222.63$65.8M
2025-12-1081$223.23$18,081.63
2025-12-0991$224.48$20,427.68
2025-12-02125$224.14$28,017.5
2025-11-241,000$227.39$227,390
2025-11-193$225.51$676.53
2025-11-171,053$221.21$232,934.13
2025-11-13764$219.40$167,621.6
2025-11-12355$215.79$76,605.45
2025-11-102$209.94$419.88
2025-11-07195$210.67$41,080.65
2025-11-041$214.06$214.06

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Price Correlations

Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.

Peer252-Day (1Y)126-Day (6M)Direction
WTGXXNaNNaN
TMO0.8190.735High co-movement
A0.7840.693High co-movement
MTD0.7650.699High co-movement
WAT0.6690.489Moderate
IQV0.6490.554Moderate
PFE0.6280.485Moderate
MRK0.5710.352Moderate
DOV0.5380.550Moderate
GEHC0.5130.491Moderate

Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.

Compare DHR to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.